Faculty profile

Michael Cox

ResearcherUrologic SciencesUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Michael Cox

Researcher

Urologic Sciences

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
3 publications in the last five years, latest in 2024.
Principal investigator on 4 research grants (4 CIHR), most recently in 2022.
Supervised 4 trainees who won CIHR awards, most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cell Stress Pathways Cholesterol Epigenetics Pharmacologic Inhibitors Prostate Cancer Scavenger Receptor-B1 Synthetic Lethal Screen Therapy Resistance

Latest papers

The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions.
Epigenomics · 2024
Indwelling stents cause severe inflammation and fibrosis of the ureter via urothelial-mesenchymal transition.
Scientific reports · 2023
Ureteral Obstruction Promotes Ureteral Inflammation and Fibrosis.
European urology focus · 2023

All 11 publications

Latest funding

Proteomics Classification of Prostate Cancer Bone Metastases
CIHR · 2025 · Supervisor
$1,500
Characterizing the three-dimensional architecture of the timor microenvironment in prostate cancer bone metastasis
CIHR · 2025 · Supervisor
$6,000
Understanding epigenetic regulation and modulation of cell stress responses by the cholesterol transporter, scavenger receptor-B1 as a novel target for treating advanced prostate cancer
CIHR · 2022 · Nominated PI
$956,250

All 11 grants and awards

11 publications.

The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions.

Wang Y, Scurll J, Rascón IA, Cui C, Ni Y, Shi AM, Gangadharannambiar P, Wang Y, Akamatsu S, Beltran H, Cox M, Crea F, Daugaard M, Dong X, Haffner M, He H, Jachetti E, Kyprianou N, Li B, Ong CE, Rickman DS, Sen T, Zhu HH, Zoubeidi A, Gleave ME

Epigenomics2024

DOI: 10.1080/17501911.2024.2391729 PMID: 39225130

Indwelling stents cause severe inflammation and fibrosis of the ureter via urothelial-mesenchymal transition.

Reicherz A, Eltit F, Scotland K, Almutairi K, Bell R, Mojtahedzadeh B, Cox M, Chew B, Lange D

Scientific reports2023

DOI: 10.1038/s41598-023-31885-1 PMID: 37015949

Ureteral Obstruction Promotes Ureteral Inflammation and Fibrosis.

Reicherz A, Eltit F, Almutairi K, Mojtahedzadeh B, Herout R, Chew B, Cox M, Lange D

European urology focus2023

DOI: 10.1016/j.euf.2022.09.014 PMID: 36244955

An Ammonia-Induced Calcium Phosphate Nanostructure: A Potential Assay for Studying Osteoporosis and Bone Metastasis.

Chen S, Wang Q, Eltit F, Guo Y, Cox M, Wang R

ACS applied materials & interfaces2021

DOI: 10.1021/acsami.1c00495 PMID: 33845570

Erythropoietin promotes functional recovery via anti-apoptotic mechanisms in mouse unilateral ureteral obstruction.

Park E, Cox M, Scotland K, Buttyan R, Lange D

Cell stress & chaperones2020

DOI: 10.1007/s12192-020-01067-3 PMID: 31970695

Adverse reactions to metal on polyethylene implants: Highly destructive lesions related to elevated concentration of cobalt and chromium in synovial fluid.

Eltit F, Assiri A, Garbuz D, Duncan C, Masri B, Greidanus N, Bell R, Sharma M, Cox M, Wang R

Journal of biomedical materials research. Part A2017

DOI: 10.1002/jbm.a.36057 PMID: 28266173

Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance.

Nouri M, Caradec J, Lubik AA, Li N, Hollier BG, Takhar M, Altimirano-Dimas M, Chen M, Roshan-Moniri M, Butler M, Lehman M, Bishop J, Truong S, Huang SC, Cochrane D, Cox M, Collins C, Gleave M, Erho N, Alshalafa M, Davicioni E, Nelson C, Gregory-Evans S, Karnes RJ, Jenkins RB, Klein EA, Buttyan R

Oncotarget2017

DOI: 10.18632/oncotarget.14850 PMID: 28145883

A low carbohydrate, high protein diet suppresses intratumoral androgen synthesis and slows castration-resistant prostate tumor growth in mice.

Fokidis HB, Yieng Chin M, Ho VW, Adomat HH, Soma KK, Fazli L, Nip KM, Cox M, Krystal G, Zoubeidi A, Tomlinson Guns ES

The Journal of steroid biochemistry and molecular biology2015

DOI: 10.1016/j.jsbmb.2015.03.006 PMID: 25797030

Prostate stromal cells express the progesterone receptor to control cancer cell mobility.

Yu Y, Lee JS, Xie N, Li E, Hurtado-Coll A, Fazli L, Cox M, Plymate S, Gleave M, Dong X

PloS one2014

DOI: 10.1371/journal.pone.0092714 PMID: 24664419

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.

Lin D, Wyatt AW, Xue H, Wang Y, Dong X, Haegert A, Wu R, Brahmbhatt S, Mo F, Jong L, Bell RH, Anderson S, Hurtado-Coll A, Fazli L, Sharma M, Beltran H, Rubin M, Cox M, Gout PW, Morris J, Goldenberg L, Volik SV, Gleave ME, Collins CC, Wang Y

Cancer research2014

DOI: 10.1158/0008-5472.can-13-2921-t PMID: 24356420

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Cell Stress Pathways Dear Professor Cox, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions." (2024), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Understanding epigenetic regulation and modulation of cell stress responses by the cholesterol transporter, scavenger receptor-B1 as a novel target for treating advanced prostate cancer" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Michael Cox

Research

Latest papers

Latest funding

The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions.

Indwelling stents cause severe inflammation and fibrosis of the ureter via urothelial-mesenchymal transition.

Ureteral Obstruction Promotes Ureteral Inflammation and Fibrosis.

An Ammonia-Induced Calcium Phosphate Nanostructure: A Potential Assay for Studying Osteoporosis and Bone Metastasis.

Erythropoietin promotes functional recovery via anti-apoptotic mechanisms in mouse unilateral ureteral obstruction.

Adverse reactions to metal on polyethylene implants: Highly destructive lesions related to elevated concentration of cobalt and chromium in synovial fluid.

Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance.

A low carbohydrate, high protein diet suppresses intratumoral androgen synthesis and slows castration-resistant prostate tumor growth in mice.

Prostate stromal cells express the progesterone receptor to control cancer cell mobility.

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.

Proteomics Classification of Prostate Cancer Bone Metastases

Characterizing the three-dimensional architecture of the timor microenvironment in prostate cancer bone metastasis

Understanding epigenetic regulation and modulation of cell stress responses by the cholesterol transporter, scavenger receptor-B1 as a novel target for treating advanced prostate cancer

Development of targeted therapeutics for ERG-expressing prostate cancers

Preventing Adverse Tissue Reactions in Total Hip Replacement, from Mechanisms to New Implant Designs

Role of Sonic Hedgehog in bladder cancer and bladder cancer stem cells

The Terry Fox New Frontiers Program on Prostate Cancer Progression (M. Gleave)

Characterizing aberrant intracellular signaling processes in ERG-transformed prostate cancer

ERG-induced transformation of prostatic epithelial cells

Investigation into the impact of certain micronutrients on lipid raft structure and associated IGF-IR signaling during prostate cancer progression

Frequent collaborators

Dirk Lange

Ben Chew

Ralph Buttyan

Martin Gleave

Amina Zoubeidi

Xuesen Dong

Yuzhuo Wang

Rizhi Wang

Mads Daugaard

Christopher Ong

Larry Goldenberg

Bassam Masri

Colin Collins

William Jia

Yu Wang

Michael Cox

Research

Latest papers

Latest funding

The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions.

Indwelling stents cause severe inflammation and fibrosis of the ureter via urothelial-mesenchymal transition.

Ureteral Obstruction Promotes Ureteral Inflammation and Fibrosis.

An Ammonia-Induced Calcium Phosphate Nanostructure: A Potential Assay for Studying Osteoporosis and Bone Metastasis.

Erythropoietin promotes functional recovery via anti-apoptotic mechanisms in mouse&#xa0;unilateral ureteral obstruction.

Adverse reactions to metal on polyethylene implants: Highly destructive lesions related to elevated concentration of cobalt and chromium in synovial fluid.

Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance.

A low carbohydrate, high protein diet suppresses intratumoral androgen synthesis and slows castration-resistant prostate tumor growth in mice.

Prostate stromal cells express the progesterone receptor to control cancer cell mobility.

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.

Frequent collaborators

Dirk Lange

Ben Chew

Ralph Buttyan

Martin Gleave

Amina Zoubeidi

Xuesen Dong

Yuzhuo Wang

Rizhi Wang

Mads Daugaard

Christopher Ong

Larry Goldenberg

Bassam Masri

Colin Collins

William Jia

Yu Wang

Erythropoietin promotes functional recovery via anti-apoptotic mechanisms in mouse unilateral ureteral obstruction.